Catechin (an anti-inflammatory, antioxidant, antitumour, and hepatoprotective bioflavonoid) is poorly absorbed across the GIT because it has multiple ring molecules that are too large to be absorbed by simple diffusion. It typically has poor miscibility with oils and other lipids which limit their ability to pass across the lipid rich outer membranes of enterocytes of small intestine. Thus catechin–phospholipid complex were prepared to improve its absorption by imparting an environment of improved lipophilicity. The phospholipid complexes of catechin were prepared with phosphatidylcholine in presence of dichloromethane by conventional solvent evaporation technique. Pharmacosomes thus prepared were evaluated for solubility, drug content, scanning electron microscopy (SEM), differential scanning calorimetry (DSC), X ray powder diffraction (XRPD), in vitro dissolution study and in vitro antioxidant activity. Prepared phospholipid complex showed high drug content (99.40%. w/w) and improved lipid solubility (0.79–1.97 mg/mL). FTIR, NMR, DSC and XRPD data confirmed the formation of phospholipid complex. Unlike the free catechin, catechin complex showed a sustained release over the 24 h of study. Catechin-phospholipid complex showed slightly better antioxidant activity than that of catechin at all dose levels. Thus it can be concluded that the phospholipid complex of catechin may be of potential use for improving absorption of catechin across the lipidic biological barriers in gastr
Lipophilic monocations can pass through phospholipid bilayers and accumulate in negatively-charged compartments such as the mitochondrial matrix, driven by the membrane potential. This property is used to visualize mitochondria, to deliver therapeutic molecules to mitochondria and to measure the membrane potential. In theory, lipophilic dications have a number of advantages over monocations for these tasks, as the double charge should lead to a far greater and more selective uptake by mitochondria, increasing their therapeutic potential. However, the double charge might also limit the movement of lipophilic dications through phospholipid bilayers and little is known about their interaction with mitochondria. To see whether lipophilic dications could be taken up by mitochondria and cells, we made a series of bistriphenylphosphonium cations comprising two triphenylphosphonium moieties linked by a 2-, 4-, 5-, 6- or 10-carbon methylene bridge. The 5-, 6- and 10-carbon dications were taken up by energized mitochondria, whereas the 2- and 4-carbon dications were not. The accumulation of the dication was greater than that of the monocation methyltriphenylphosphonium. However, the uptake of dications was only described by the Nernst equation at low levels of accumulation, and beyond a threshold membrane potential of 90–100 mV there was negligible increase in dication uptake. Interestingly, the 5- and 6-carbon dications were not accumulated by cells, due to lack of permeation through
Everything we examined (2)
This check searched the claim as stated. It did not run a separate search for evidence against it.